中国药物警戒 ›› 2011, Vol. 8 ›› Issue (8): 504-505.

• 药品不良反应监测 • 上一篇    下一篇

92例特拉唑嗪不良反应/事件报告分析

彭丹冰1, 彭源2   

  1. 1 贵州省药品不良反应监测中心,贵州 贵阳 550000;
    2 武警贵州省总队医院,贵州 贵阳 550000
  • 收稿日期:2011-04-08 出版日期:2011-08-10 发布日期:2015-07-30
  • 作者简介:彭丹冰,女,博士,副主任医师,药物上市后研究。

Analysis of 92 Cases of Adverse Drug Reacation/Event of Terazosin

PENG Dan-bing1, PENG Yuan2   

  1. Guizhou Center for ADR Monitoring, Guizhou Guiyang 550004, China; 2Guizhou People's Armed Police Corps Hospital, Guizhou Guiyang 550004, China
  • Received:2011-04-08 Online:2011-08-10 Published:2015-07-30

PDF (PC)

143

摘要： 目的 初步了解和分析特拉唑嗪发生不良反应/事件的情况,为临床合理用药提供参考依据。方法 对笔者对收集的2006~2009年间某院92例特拉唑嗪所致不良反应/事件报告进行回顾性分析。结果 92例不良反应/事件报告中,男性远多于女性,全部是18岁以上的成年患者,其中以中老年患者居多;不良反应的临床表现以神经系统、心脏及循环系统损害最为常见。结论 医疗机构应重视特拉唑嗪的不良反应,加强对其临床应用的监管。

关键词: 特拉唑嗪, 药品不良反应/事件

Abstract: Objective To investigate the situation of adverse drug reaction/event(ADR/ADE) of Terazosin, and provide bases and references for rational use of Terazosin. Methods 92 ADR reports of Terazosin were collected and analyzed in a hospital from 2006 to 2010. Results In 92 reports, males were far more than females. Adult patients that older than 50 years were accounted for the majority(66.3%). The damage to the nervous system and cardiovascular system were the commonest type. Conclusion We should pay attention to the ADR/ADE of Terazosin, and strengthen the supervision of clinical application of Terazosin.

Key words: Terazosin, adverse drug reaction/event(ADR/ADE)

中图分类号: